APP ubiquitination by VHL protein is essential for MVB sorting and lysosomal degradation

Chunyan Shan1, Rixu Cong1, Xiangyu Xu1

  • 1Key Laboratory of Cell Proliferation and Differentiation of the Ministry of Education, School of Life Sciences, Peking University, Beijing 100871, China.

PubMed

Insights

The von Hippel-Lindau protein (VHL) targets amyloid precursor protein (APP) for degradation, reducing Alzheimer's disease (AD) pathology. Loss of VHL accelerates Aβ plaque deposition and memory deficits in AD mice.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Cell Biology

Background:

  • Alzheimer's disease (AD) pathogenesis involves amyloid precursor protein (APP) and amyloid beta (Aβ) accumulation.
  • Mechanisms of APP sorting and lysosomal degradation are not fully understood.
  • APP is processed in the Golgi and endosomes, leading to toxic Aβ generation.

Purpose of the Study:

  • To investigate the role of the von Hippel-Lindau protein (VHL) in APP processing and degradation.
  • To elucidate the mechanisms by which VHL influences APP trafficking and lysosomal degradation.
  • To determine the impact of VHL on Alzheimer's disease pathology.

Main Methods:

  • Studied the interaction between VHL and the cytoplasmic domain of APP.
  • Investigated VHL-mediated ubiquitination of APP.
  • Examined the effect of VHL on APP sorting into multivesicular bodies (MVBs) and lysosomal degradation.
  • Utilized Alzheimer's disease model mice to assess the in vivo role of VHL.

Main Results:

  • VHL recognizes and ubiquitinates the cytoplasmic domain of APP.
  • VHL-mediated ubiquitination promotes APP sorting into intraluminal vesicles of MVBs.
  • This sorting facilitates lysosomal degradation of APP.
  • Loss of VHL accelerates Aβ plaque deposition and memory deficits in AD model mice.

Conclusions:

  • VHL plays a critical role in restricting Alzheimer's disease pathogenesis.
  • VHL facilitates APP degradation via ubiquitination-dependent MVB sorting and lysosomal pathways.
  • Targeting VHL may offer a therapeutic strategy for Alzheimer's disease.

Related Concept Videos

Intralumenal Vesicles and Multivesicular Bodies01:38

Intralumenal Vesicles and Multivesicular Bodies

Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
4.7K
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
8.7K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.8K
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
5.0K
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.6K
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
10.1K